Licensed compounding pharmacy network

Compounding supply, without the guesswork.

Cushman Clinical Partners represents a network of licensed compounding pharmacies fulfilling to all 50 states. GLP‑1s, hormone therapy, peptides, sexual health, hair loss, and IV therapy under one supply relationship. We work with prescribers, medical directors, and practice owners, never with patients.

Clinics only Prescriber required 503A patient-specific 503B office stock Professional-use line All 50 states
01One network503A patient-specific, 503B office stock, and a professional-use line under a single relationship.
02Wide formularyGLP‑1s, hormone therapy, peptides, sexual health, hair loss, IV therapy, and more.
03One point of contactYou reach a person who knows your account, not a queue.
04Straight answersIncluding when the honest answer is “not yet, and here's why.”

01  /  The supply conversation

You already have a pharmacy. You probably already have a complaint.

Most clinics running a hormone, weight-management, or in-office injection program work with a single compounding pharmacy and quietly live with whatever that pharmacy is worst at: turnaround, formulary gaps, inconsistent supply, or a rep who stopped returning calls.

Our role is narrow and practical: understand what a practice actually needs, then put the right people in front of each other so questions about formulary, turnaround, and what a pharmacy can legally ship to your state get answered by someone qualified to answer them. This is a supply conversation. We do not advise on clinical protocols, and we do not sell to patients.

The network is anchored by Logos, a 503A compounding pharmacy, with partner pharmacies alongside it and a 503B channel for office stock. Formulary, pricing, and turnaround come from the pharmacy team directly, on the intro call, in writing.

Section 503A

Patient-specific compounding

Medications compounded to a prescription written for one named patient, the standard route for most outpatient programs.

  • Prescription-driven, per patient
  • Where most clinic relationships already sit
  • Formulary breadth is the differentiator
One
relationshipBoth lanes
Section 503B

Office stock

Outsourcing-facility product a practice can hold as inventory without a patient-specific prescription. Relevant to any clinic administering treatment on site.

  • Infusion suites, IV therapy, in-office injection
  • A purchasing decision, not a clinical one
  • Most clinics don't realize it's on the table
Professional-use line

Pharmaceutical-grade, for your practice

A pharmaceutical-grade, third-party-tested product line for professional use in clinical settings. This is manufactured product with documentation to match, not a research-chemical channel.

  • Manufactured and third-party tested
  • Documentation your practice can keep on file
  • Professional use only, never sold to consumers
One relationship

What working with us includes

A 15-minute intro call with the network's leadership covering formulary, pricing, and turnaround for the preparations your practice actually uses. Specifics, not a pitch.

  • Numbers from the pharmacy team, in writing
  • Onboarding and credentialing that don't sit in a queue
  • A standing escalation path: something's late, you call us

02  /  How we work

We would rather lose the sale than give you bad information.

Compounding is a moving regulatory target, and a fair amount of what gets told to clinics about what is and isn't available is wrong, sometimes carelessly, sometimes on purpose. A practice cannot make a good purchasing decision on bad information, so here is how we handle it.

01

If it isn't available, we say so.

Some products get talked about as though they're already on the table when the rulemaking that would allow it hasn't happened. We'll tell you where something actually sits today, including when the answer is no.

02

If it's above our pay grade, we hand it off.

Formulary, turnaround, and what your state actually allows get answered by the pharmacy's leadership, not by a rep guessing on a doorstep. We put you on the phone with the people who actually know.

03

We don't quote what we can't supply.

Nothing gets promised to your practice that the network isn't currently able to fill. If capacity or formulary changes, you hear it from us before it becomes your problem.

The useful question isn't whether someone will sell it to you. It's whether a licensed pharmacy may lawfully compound it today, for your practice, in your state. Ask us that before you order anywhere. We'll answer it plainly, and we'll tell you when the answer is no.

Cushman Clinical Partners is not a pharmacy and does not compound, manufacture, or dispense. We represent licensed compounding pharmacies and outsourcing facilities, and we work only with licensed medical practices and prescribers.

03  /  Who we work with

Independent and small-group practices with a licensed prescriber on staff.

Hormone replacement & TRT
Functional & integrative medicine
Medical weight management
IV therapy & infusion
Regenerative & sports medicine
Concierge & direct primary care

04  /  Who you're dealing with

One person, and he actually shows up.

Grant Gilmer, Founder, Cushman Clinical Partners
Grant GilmerFounder

Cushman is a small operation on purpose. You get one point of contact who actually knows your account, and when it's practical I come to the clinic myself rather than sending an email and hoping. A few minutes at your front desk, and I'll leave you something worth keeping whether or not there's a fit.

When there is a fit, I don't try to answer questions I'm not qualified to answer. I put you directly on the phone with the pharmacy network's leadership so formulary, turnaround, and state rules get handled at the source.

Set up a call

05  /  Contact

Tell us where your current supplier falls short.

If it's a fit, we'll arrange a direct call with the pharmacy network's leadership so formulary, turnaround, and state-by-state rules get answered at the source.

Phone (470) 971-3131
Grant Gilmer, Founder
Email grant@cushmanclinical.com
Typically same-day response